Is the Ramsay Health Care Limited share price now in the buy zone?

Unfortunately for its shareholders the Ramsay Health Care Limited (ASX: RHC) share price has gone nowhere so far this year.

This is especially disappointing considering the S&P/ASX 200 Health Care (Index: ^AXHJ) (ASX: XHJ) is up a remarkable 17% year-to-date.

Is Ramsay in the buy zone?

I think it is. While market volatility may present even better buying opportunities in the future, I believe those that are prepared to make a long-term buy and hold investment will do very well with an investment at the current share price.

After all, with a sharp increase in ageing populations around the world, demand for healthcare services is expected to increase substantially over the next few decades.

According to a recent presentation, the global population aged 60 or above is expected to more than triple by 2050.

In my opinion there are few companies better positioned to meet this demand than Ramsay.

Its global network currently consists of 25,000 hospital beds across 233 hospitals, 1,150 operating theatres, 38 emergency departments, 15 healthcare and treatment facilities, and 200 pharmacies.

Impressively I expect these numbers to rise strongly over the next decade as the company takes advantage of brownfield and greenfield expansion opportunities.

Furthermore, I wouldn’t be at all surprised to see the company expand into the massive China market in the future. Especially as management has pointed out the chronic disease opportunity in the country numerous times in the past.

With an estimated 83 million diabetics in the country and a wealthy and ageing population, it seems like a natural fit for Ramsay if it can navigate successfully through strict regulations.

So although its shares are changing hands at a reasonably expensive 27x annualised earnings, I believe they are worth every cent.

In light of this, I would invest in Ramsay ahead of its peers Healthscope Ltd (ASX: HSO) and Primary Health Care Limited (ASX: PRY) today.

Like Ramsay, I expect the tailwinds these growth shares are experiencing will make them great buy and hold investments as well.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.

The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.